Brooks Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve and take on record the ....
BROOKS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brooks Laboratories Ltd has informed the stock exchanges that its Board of Directors will meet on Friday, 14th November 2025 to consider and approve the Unaudited Financial Results (both Standalone and Consolidated) for the quarter and half year ended 30th September 2025, along with the Limited Review Report from its Statutory Auditors. The trading window for Directors, Designated Persons, and their immediate relatives has been closed since 1st October 2025 and will reopen 48 hours after the results are declared. The company has a Scrip Code of 533543 on BSE and trades under the symbol BROOKS.
This is a routine pre-result intimation and does not, by itself, move the stock. Investors should watch 14th November 2025 for the actual Q2/H1 FY26 numbers, which could trigger a short-term reaction depending on performance versus expectations.